Kim Gale  |  January 19, 2018

Category: Legal News

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Xarelto bleeding emergency roomThe estate of a woman who died of a Xarelto hemorrhagic stroke has filed a lawsuit against the drug’s makers, Janssen Pharmaceuticals, Johnson & Johnson and Bayer Healthcare.

Decedent Barbara B. allegedly took Xarelto from January 2016 to March 2016. She suffered a retinal hemorrhage on March 16, 2016, and on March 23, 2016, she suffered a Xarelto hemorrhagic stroke. She died on March 25, 2016.

Xarelto belongs to the class of New Oral Anticoagulants (NOACs) and was FDA-approved in July 2011. The blood thinner was marketed as a better alternative to Coumadin (warfarin), which has been a trusted medication for the past 60 years.

Xarelto was marketed as a more convenient medication. Unlike warfarin, Xarelto required no blood testing to ensure a therapeutic level was maintained in the patient’s system. Xarelto was advertised as a “one dose fits all” medication that was taken just once daily.

The marketing campaign called this the “Xarelto Difference,” but according to the Xarelto hemorrhagic stroke lawsuit, “’the Xarelto Difference’ was nothing more than a marketing campaign based on flawed science.”

The “Xarelto Difference” marketing campaign enabled the drug to bring in more than $580 million in global sales during its first full year on the market.

Allegations of Xarelto Hemorrhagic Stroke Lawsuit

Barbara trusted that Xarelto was a blood thinner that would prevent her from experiencing blood clots and strokes. What she didn’t know was that Xarelto hid some important facts from her and from other patients, according to the plaintiff representing her estate.

Among the problems with Xarelto:

  • Xarelto has no available antidote. In the event of an accident or surgery, the blood-thinning actions of warfarin can be reversed with an IV dose of vitamin K. There is no such reversal agent for Xarelto.
  • Even though Xarelto is marketed as an easy once-daily dose, an FDA advisory committee found that if dosed twice daily, Xarleto would maintain a steady level in the blood instead of going through peaks and valleys of medication levels throughout the day.
  • Although Xarelto boasts that no blood monitoring is needed, doctors need to find a dose that thins the blood enough to reduce the risks of a stroke, but not thinned to the point of causing uncontrollable bleeding.

The Xarelto hemorrhagic stroke lawsuit accuses the drug’s makers of failing to warn patients and healthcare workers “regarding the need for blood monitoring, dose adjustments, and failed to warn of the risk of serious bleeding that may be irreversible, permanently disabling, and life-threatening, associated with Xarelto.”

Because Xarelto’s premarket studies were flawed and inadequate, the drug’s warning label was inadequate as well, alleges the complaint.

Despite the millions of dollars spent on marketing campaigns, Xarelto was “unsafe, defective, and inherently dangerous” to patients who trusted the medication was a state-of-the-art answer to their risks of blood clots and strokes.

The Xarelto Hemorrhagic Stroke Lawsuit is Case No. 2:17-cv-17810-EEF-MBN in the U.S. District Court for the Eastern District of Louisiana.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More

Get Help – It’s Free

Join a Free Xarelto Class Action Lawsuit Investigation

If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

Please Note: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client, if you qualify, or getting you dropped as a client.

Oops! We could not locate your form.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.


Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.